Clinical trial
The Effect of Linagliptin on Mitochondrial and Endothelial Function
NCT01969084 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Linagliptin on Mitochondrial and Endothelial Function
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2013
- Completion date
- July 31, 2016
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type ii diabetes mellitus